Vicente Aldasoro

Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice

Monica Calderón-Goercke, J. Loricera, Vicente Aldasoro et al. · Seminars in Arthritis and Rheumatism · 2019 · 105 citations · Full text

Rheumatology, Autoimmune Disease, Vasculitis +6

Tocilizumab in giant cell arteritis: differences between the GiACTA trial and a multicentre series of patients from the clinical practice.

Monica Calderón-Goercke, Santos Castañeda, Vicente Aldasoro et al. · PubMed · 2020 · 34 citations

Tocilizumab in refractory giant cell arteritis. Monotherapy versus combined therapy with conventional immunosuppressive drugs. Observational multicenter study of 134 patients

Monica Calderón-Goercke, Santos Castañeda, Vicente Aldasoro et al. · Seminars in Arthritis and Rheumatism · 2021 · 25 citations

Autoimmune Disease, Vasculitis, Monotherapy Versus +6

Tocilizumab in visual involvement of giant cell arteritis: a multicenter study of 471 patients

J. Loricera, Santos Castañeda, C. Moriano et al. · Therapeutic Advances in Musculoskeletal Disease · 2022 · 24 citations · Full text

Optimisation of tocilizumab therapy in giant cell arteritis. A multicentre real-life study of 471 patients

Monica Calderón-Goercke, J. Loricera, C. Moriano et al. · Clinical and Experimental Rheumatology · 2022 · 24 citations